Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
J Biomater Sci Polym Ed ; : 1-16, 2024 Jun 26.
Article in English | MEDLINE | ID: mdl-38923918

ABSTRACT

This study aimed to synthesize and characterize chitosan-coated noisomal doxorubicin for the purpose of enhancing its medical application, particularly in the field of cancer treatment. Doxorubicin, a potent chemotherapeutic agent, was encapsulated within noisomes, which are lipid-based nanocarriers known for their ability to efficiently deliver drugs to target sites. Chitosan, a biocompatible and biodegradable polysaccharide, was used to coat the surface of the noisomes to improve their stability and enhance drug release properties. The synthesized chitosan-coated noisomal doxorubicin was subjected to various characterization techniques to evaluate its physicochemical properties. Transmission electron microscopy (TEM) revealed a spherical structure with a diameter of 500-550 ± 5.45 nm and zeta potential of +11 ± 0.13 mV with no aggregation or agglomeration. Chitosan-coated noisomes can loaded doxorubicin with entrapping efficacy 75.19 ± 1.45%. While scanning electron microscopy (SEM) revealed well-defined pores within a fibrous surface. It is observed that chitosan-coated niosomes loading doxorubicin have optimum roughness (22.88 ± 0.71 nm). UV spectroscopy was employed to assess the drug encapsulation efficiency and release profile. Differential scanning calorimetry (DSC) helped determine the thermal behavior, which indicated a broad endotherm peak at 52.4 °C, while X-ray diffraction (XRD) analysis provided information about the crystallinity of the formulation with an intense peak at 23.79°. Fourier-transform infrared spectroscopy (FTIR) indicated the formation of new bonds between the drug and the polymer. The findings from this study will contribute to the knowledge of the physical and chemical properties of the synthesized formulation, which is crucial for ensuring its stability, drug release kinetics, and biological activity. The enhanced chitosan-coated noisomal doxorubicin has the potential to improve the effectiveness and safety of doxorubicin in cancer treatment, offering a promising strategy for enhanced medical applications.

2.
BMC Oral Health ; 22(1): 13, 2022 01 18.
Article in English | MEDLINE | ID: mdl-35042489

ABSTRACT

BACKGROUND: In recent years, pediatric endodontics has witnessed various advances including use of rotary files in pulpectomy. This study aimed to comparatively evaluate taper, amount of dentin removal and instrumentation time of the pediatric rotary Kedo-S Square file, hand K-files and H-files in primary canines using cone beam computed tomography (CBCT). METHODS: 60 primary canines were randomly assigned into three groups; A1 Kedo-S-Square rotary file (group I), hand stainless steel K file (group II) and hand stainless steel H file (group III). Teeth were mounted in vinyl poly siloxane impression material templates to be scanned before and after instrumentation by CBCT scans using Ondemand 3D software. Shaping ability of the files were evaluated in terms of taper of the canal and amount of dentin remaining of each group. Instrumentation time was recorded using a digital stopwatch. RESULTS: Kedo-S Square removed a significantly less amount of dentin in both apical (P < 0.002) and coronal thirds (P < 0.014). Taper of the preparations showed significant differences as Kedo-S Square file showed good taper in maximum number of root canals, while maual K- and H-files showed poor taper in maximum number of root canals (P < 0.0001). Rotary Kedo-S Square files required less instrumentation time (P < 0.0001). CONCLUSION: The use of rotary Kedo-S Square files resulted in better conservation of tooth structure, superior tapering ability and least instrumentation time compared to hand K- and H-files.


Subject(s)
Root Canal Preparation , Spiral Cone-Beam Computed Tomography , Child , Cone-Beam Computed Tomography/methods , Humans , Molar , Tooth, Deciduous
3.
Appl Biochem Biotechnol ; 185(1): 153-162, 2018 May.
Article in English | MEDLINE | ID: mdl-29098560

ABSTRACT

Ovarian malignancy is diagnosed in nearly a fourth of a million women internationally every year. Methylation of RASSF1A tumor suppressor gene prompts its inactivation in diseases. In this study, the RASSF1A promoter methylation was detected by methylated-specific PCR and investigated serum RASSF1A protein level through enzyme-linked immunosorbant assay in 160 Egyptian patients with ovarian cancer and 160 healthy controls. The present work proved that there was a higher frequency of RASSF1A methylation and a decrease in its serum level in patients with ovarian cancer compared to controls as well as in the high-grade tumor patients compared to low grade ones and also in advanced ovarian tumor stage compared to early stages. Our study exhibited that RASSF1A promoter hypermethylation and its protein levels may be a reliable and sensitive tool for diagnosing and monitoring of ovarian malignancy patients.


Subject(s)
DNA Methylation , DNA, Neoplasm , Ovarian Neoplasms , Promoter Regions, Genetic , Tumor Suppressor Proteins , Adult , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Egypt , Female , Humans , Middle Aged , Ovarian Neoplasms/genetics , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
4.
Gene ; 610: 127-132, 2017 Apr 30.
Article in English | MEDLINE | ID: mdl-28215593

ABSTRACT

OBJECTIVE: To investigate the association between increased carotid intima-media thickness (CIMT), homocysteine level, and MTHFR C677T (rs1801133) gene polymorphism in Egyptian people with rheumatoid arthritis (RA). SUBJECTS AND METHODS: 280 Egyptian women (160 RA patients and 120 controls) were included in the study. CIMT was measured using high resolution B-mode ultrasonography and homocysteine levels were measured using enzyme-linked immunosorbent assay. While, MTHFR C677T polymorphism was analyzed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: We found that subjects who carried the TT genotype and T allele were significantly more likely to develop RA with 2.9 and 1.5 fold, respectively. RA patients carrying the T allele presented a statistically significant increased risk of developing atherosclerosis compared with those carrying the C allele. Moreover, MTHFR TT genotype was independent risk factor of thick CIMT. CONCLUSIONS: C677T MTHFR gene polymorphism is associated with RA in Egyptians. MTHFR 677TT carriers had higher concentrations of serum Hcy than did subjects harboring the CC and CT genotypes. The presence of 677T allele increases the risk of atherosclerosis in patients with RA. This increased risk of atherosclerosis could be due to hyperhomocysteinemia.


Subject(s)
Arthritis, Rheumatoid/complications , Atherosclerosis/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Point Mutation , Adult , Arthritis, Rheumatoid/blood , Carotid Intima-Media Thickness , Egypt , Female , Genetic Predisposition to Disease , Homocysteine/blood , Humans , Regression Analysis
5.
Int J Cardiol ; 227: 524-528, 2017 Jan 15.
Article in English | MEDLINE | ID: mdl-27825726

ABSTRACT

OBJECTIVES: Matrix metalloproteinases (MMPs) play an important role in the pathogenesis of coronary artery disease (CAD). This study aims to determine the association of MMP-9 genotype polymorphisms and its serum levels with the risk of acute myocardial infarction (AMI) in Egyptian patients. Also, it evaluated their role as predictors of AMI outcome after six months follow-up. METHODS: Subjects included in the study were 184 patients with AMI and 180 controls. Genotyping of MMP-9-1562C>T polymorphism was carried out by PCR-based restriction digestion method. Serum MMP-9 was measured using ELIZA assay. All patients were followed for AMI complications during their hospitalization and 6 months later on. RESULTS: MMP-9-1562T allele was more frequent in patients than in controls (OR=1.65, 95%CI 1.09-2.15, P=0.011). the frequency of CT+TT genotypes were higher in patients with morbidity (OR=2.85, 95%CI 1.29-6.29, P=0.008) and with mortality (OR=3.21, 95%CI 1.28-8.02, P=0.012) than in those without MI complications. Serum MMP-9 levels were significantly elevated in AMI as compared to controls and more associated with TT genotype. The impairment of LV function (ΔEF, ΔLAD, ΔE/A) was more observed in the TT genotype compared with CC genotype. CONCLUSIONS: Our data suggest that MMP-9 (TT genotype) and its serum level are associated with the risk of suffering AMI in Egyptians. In addition, MMP-9 polymorphism and its level might be useful clinical biomarkers for predicting the outcome of AMI.


Subject(s)
Gene Expression Regulation , Matrix Metalloproteinase 9/blood , Matrix Metalloproteinase 9/genetics , Myocardial Infarction/genetics , Polymorphism, Genetic , Aged , Analysis of Variance , Biomarkers/blood , Case-Control Studies , Chi-Square Distribution , Echocardiography/methods , Egypt , Enzyme-Linked Immunosorbent Assay , Female , Hospitals, University , Humans , Male , Middle Aged , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Predictive Value of Tests , Prognosis , Risk Assessment , Severity of Illness Index , Survival Analysis , Ventricular Dysfunction, Left/mortality , Ventricular Dysfunction, Left/physiopathology
6.
Genet Test Mol Biomarkers ; 20(5): 249-54, 2016 May.
Article in English | MEDLINE | ID: mdl-26914636

ABSTRACT

BACKGROUND: Bone disease in rheumatoid arthritis (RA) is a complex phenomenon where genetic risk factors have been partially evaluated. In the present study, we aimed to evaluate the relationship between polymorphisms of the receptor activator of the nuclear factor kappa B (RANK) gene; the receptor activator of the nuclear factor kappa B ligand (RANKL) gene; and RANKL levels with osteoporosis in postmenopausal RA patients. DESIGN AND METHODS: One hundred seventy-two postmenopausal female patients and 176 age- and sex-matched controls were enrolled in the study. All subjects were genotyped for the presence of RANK C575T (rs1805034) and RANKL C290T (rs9525641) gene polymorphisms. RANKL levels, bone mineral density (BMD), and biochemical markers were also obtained. RESULTS: Women with the RANK CC genotype were significantly (2X) more likely to develop osteoporosis than those with the TT genotype (p = 0.024). A significant association was also observed between the RANKL 290TT genotype and both BMD and RANKL levels. In addition, individuals with the -290TT genotype were twice as likely to develop osteoporosis as those with the CC genotype (p < 0.001). CONCLUSIONS: Postmenopausal women with RA, carrying either the RANKL-290T allele or possessing the RANK 575CC genotype were more likely to develop osteoporosis. Moreover, our results suggested that the polymorphism 290C>T could be considered a risk factor for genetic susceptibility to osteoporosis and low BMD.


Subject(s)
Arthritis, Rheumatoid/genetics , Osteoporosis, Postmenopausal/genetics , Polymorphism, Single Nucleotide , RANK Ligand/genetics , Receptor Activator of Nuclear Factor-kappa B/genetics , Aged , Arthritis, Rheumatoid/complications , Bone Density/genetics , Case-Control Studies , Female , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Humans , Middle Aged , Osteoporosis, Postmenopausal/complications
7.
Nutrition ; 32(4): 478-85, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26732833

ABSTRACT

OBJECTIVES: Tumor necrosis factor α (TNF-α) is implicated in the pathophysiology of renal obstruction through its interactions with two TNF-α receptors: TNFR1 and TNFR2. Activation of TNFR1 leads to the recruitment of the adaptor TNFR-associated death domain protein (TRADD), which binds the Ser/Thr kinase receptor-interacting protein (RIP) and TNFR-associated factors 2 (TRAF2). This TRADD-RIP-TRAF complex causes activation of the antiapoptotic pathway and inhibits caspase 8 activation. Meanwhile, activation of TNFR2 leads to depletion of TRAF2 and enhancement of the apoptotic pathway. Curcumin, the major component found in turmeric spice, has been reported to possess a protective role against renal injury elicited by unilateral ureteral obstruction (UUO). The present study aimed mainly to address the cytoprotective role of curcumin-rich diet (5% w/w) on the apoptotic pathway induced by UUO in rats after 30 d of ligation. METHODS: The levels of mRNA for TNFR1, TNFR2, RIP, TRAF2, and caspase 8 were measured by reverse transcription-polymerase chain reaction. The levels of TNF-α was determined by ELISA. Kidney sections were exposed to histologic and morphometric studies. RESULTS: Administration of curcumin decreased TNF-α, TNFR2, and caspase 8 without affecting TNFR1 levels. The gene expression levels of the antiapoptotic molecules RIP and TRAF2 were increased. CONCLUSIONS: The cytoprotective role of curcumin relies on its ability to decrease the TNFR2 mRNA and enhance the antiapoptotic molecules RIP and TRAF2 to decrease the apoptotic pathway via decreasing the caspase 8.


Subject(s)
Curcumin/pharmacology , Receptors, Tumor Necrosis Factor, Type II/metabolism , TNF Receptor-Associated Factor 2/metabolism , Ureteral Obstruction/drug therapy , Ureteral Obstruction/genetics , Animals , Apoptosis/drug effects , Caspase 8/genetics , Caspase 8/metabolism , Curcuma/chemistry , Disease Models, Animal , Gene Expression Regulation , Kidney/drug effects , Kidney/metabolism , Male , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptor-Interacting Protein Serine-Threonine Kinases , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor, Type I/metabolism , Receptors, Tumor Necrosis Factor, Type II/genetics , TNF Receptor-Associated Factor 2/genetics
8.
Gene ; 561(1): 107-14, 2015 Apr 25.
Article in English | MEDLINE | ID: mdl-25680288

ABSTRACT

The present study was designed to investigate whether spermatogonial stem cells (SSCs) have possible effect on doxorubicin (DOX)-induced testicular apoptosis and damaged oxidant/antioxidant balance in rats. Sixty male Albino rats were divided into 3 groups: the saline control group, the testicular toxicity group (2mg/kg DOX once a week for 8 weeks) and the third group is a donor stem cells transplanted following pre-treatment with DOX. After the 8th week, the rats were sacrificed and tissues were collected and examined for CD95, CD95L, Caspase 3, and Caspase 8 gene expression using RT-PCR. While malondialdehyde (MDA), glutathione peroxidase (GSH-Px), catalase (CAT), and superoxide dismutase (SOD) were determined using colorimetric kits. Biochemical, histopathological and PCR results showed improvement of the SSCs' group compared to the DOX-group. It was observed that spermatogonial stem cell affected DOX-induced activation of intrinsic apoptotic signaling pathway via preventing DOX-induced increases in CD95 and CD95L levels as well as cleaved Caspase-8 and Caspase-3 levels in testicular tissues, however, spermatogonial stem cell decreased Dox-induced NF-κB activation as well. It can be concluded that SSCs may be utilized to develop new cell-based therapies, and to advance germline gene therapy.


Subject(s)
Adult Stem Cells/transplantation , Antibiotics, Antineoplastic/toxicity , Apoptosis/drug effects , Cell- and Tissue-Based Therapy/methods , Doxorubicin/toxicity , Animals , Antibiotics, Antineoplastic/pharmacology , Caspase 3/biosynthesis , Caspase 8/biosynthesis , Catalase/metabolism , Doxorubicin/pharmacology , Enzyme Activation , Fas Ligand Protein/biosynthesis , Gene Expression , Glutathione Peroxidase/metabolism , Male , Malondialdehyde/metabolism , NF-kappa B/metabolism , Oxidation-Reduction , Oxidative Stress/drug effects , Rats , Seminiferous Tubules/physiology , Signal Transduction , Sperm Count , Sperm Motility , Sperm Retrieval , Spermatozoa/physiology , Superoxide Dismutase/metabolism , Testis/drug effects , fas Receptor/biosynthesis
9.
J Clin Lipidol ; 8(4): 381-9, 2014.
Article in English | MEDLINE | ID: mdl-25110219

ABSTRACT

BACKGROUND: Epidemiological studies have shown a strong inverse relationship between high-density lipoprotein (HDL) cholesterol (HDLc) levels and coronary artery disease (CAD), and a low concentration of plasma HDLc is considered an independent risk factor for premature atherosclerosis. Mutations in ATP-binding cassette A1 transporter (ABCA1), cholesteryl ester transfer protein (CETP), and lecithin: cholesterol acyltransferase (LCAT) reduce HDLc in humans. OBJECTIVE: To date, no study had tested the association between these polymorphisms and premature CAD (PCAD) in the Egyptian population. Here we searched for ABCA1 (rs2230806), CETP (rs708272), and LCAT (rs5923) mutations in the Egyptian population and investigated the possible association between these gene polymorphisms and PCAD. We aimed to investigate the association between ABCA1, CETP, and LCAT gene polymorphisms and PCAD in Egyptians. METHODS: A total of 235 Egyptians-116 with documented PCAD (PCAD group) and 119 controls-were enrolled in the study. RESULTS: Mutation carriers with low HDLc had an elevated risk of PCAD (odds ratio [OR] = 11.38 for ABCA1 mutation carriers, P = .000; OR = 5.41 for CETP mutation carriers, P = .000; OR = 5.92 for LCAT mutation carriers, P = .000). Moreover, mutations in ABCA1, CETP, and LCAT were significantly associated with hyperlipidemia in this study. CONCLUSION: These observations show that the R allele of ABCA1, the B1 allele of CETP, and the T allele LCAT genes are associated with PCAD in Egyptians. They have more considerable effect on patients with low HDLc.


Subject(s)
ATP Binding Cassette Transporter 1/genetics , Cholesterol Ester Transfer Proteins/genetics , Coronary Artery Disease/genetics , Hyperlipidemias/genetics , Phosphatidylcholine-Sterol O-Acyltransferase/genetics , Adult , DNA Mutational Analysis , Egypt , Female , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Mutation/genetics , Polymorphism, Single Nucleotide , Risk
10.
Gene ; 532(2): 216-21, 2013 Dec 15.
Article in English | MEDLINE | ID: mdl-24055729

ABSTRACT

The aim of this study was to investigate the association between C-reactive protein (CRP) gene polymorphism and metabolic syndrome (MetS) with premature coronary artery disease (PCAD). 116 patients with PCAD (58 with MetS and 58 without MetS) and 119 controls were included in the study. CRP gene +1059 G>C polymorphism was analyzed by polymerase chain reaction. Serum hs-CRP was measured using high-sensitivity enzyme-linked immunosorbent assay. Carriers of C allele of the CRP +1059 G>C polymorphism had 3.37 fold increased risk to develop MetS in patients with PCAD. In addition CRP gene and hs-CRP levels were independent risk factors for PCAD and MetS. The present study provides new evidence that the presence of CRP +1059 G>C polymorphism and hs-CRP levels are independent determinants of PCAD and MetS in Egyptians. The results of our study suggest a synergistic effect of CRP C allele with classical risk factors such as hypertension, obesity, dyslipidemia and MetS.


Subject(s)
C-Reactive Protein/genetics , Coronary Artery Disease/genetics , Metabolic Syndrome/genetics , Polymorphism, Single Nucleotide , Adult , Case-Control Studies , Coronary Artery Disease/etiology , Egypt , Female , Gene Frequency , Genetic Association Studies , Humans , Male , Metabolic Syndrome/complications , Middle Aged , Risk Factors
11.
Exp Toxicol Pathol ; 65(1-2): 197-203, 2013 Jan.
Article in English | MEDLINE | ID: mdl-21920723

ABSTRACT

Cisplatin is one of the most important chemotherapeutic agents useful in the treatment of a variety of solid tumors; however, it has several side effects such as nephrotoxicity. In the present study, the effect of rhEPO on acute kidney injury induced by i.p. injection of rats with 9.0 mg/kg cisplatin was studied. It was observed that EPO treated group showed a significantly lower rate in the extent and severity of the histological signs of kidney injury than untreated one. This is attributed to (i) a decrease in the elevated oxidative and nitrosative stress markers, (ii) reduction of the expression of VEGF, HO-1 and iNOS as well as (iii) improvement of Bcl2 immunoreaction in most tubular cells. Thus, EPO may be one of the futures therapeutic possibilities to overcome the side effects of anti-cancer drugs induced acute renal injury through various mechanisms including down regulation of vascular endothelial growth factor (VEGF), hemeoxygenase-1 (HO-1) and inducible nitric oxide synthase (iNOS) expressions in addition to stimulation of tubular cell regeneration.


Subject(s)
Acute Kidney Injury/prevention & control , Antineoplastic Agents/toxicity , Cisplatin/toxicity , Erythropoietin/therapeutic use , Acute Kidney Injury/chemically induced , Acute Kidney Injury/metabolism , Acute Kidney Injury/pathology , Animals , Antineoplastic Agents/administration & dosage , Blood Cell Count , Cisplatin/administration & dosage , Disease Progression , Electrophoresis, Agar Gel , Erythropoietin/administration & dosage , Gene Expression/drug effects , Kidney Function Tests , Male , Nitric Oxide Synthase Type II/genetics , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor A/genetics
12.
Cytokine ; 60(1): 271-6, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22682513

ABSTRACT

BACKGROUND: Host genetic factors may affect clinical outcomes of hepatitis C virus (HCV) infection; however, the possible mechanisms remain largely unknown. This study aimed to evaluate transforming growth factor-ß1 (TGF-ß1)-509 and tumor necrosis factor-α (TNF-α)-308 genes polymorphisms as a risk factors for cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis C patients. MATERIALS AND METHODS: Two hundred and eighty HCV patients (152 patients with cirrhosis, 128 patients with HCC) and 160 controls were enrolled in the study. Polymorphisms of TGF-ß1-509 and TNF-α-308 gene were determined using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Serum TGF-ß1 and TNF-α were determined using ELISA. RESULTS: TGF-ß1-509 TT, TNF-α-308 AA and GA genotypes frequencies were significantly increased in cirrhotic and HCC groups. Serum TGF-ß1 and TNF-α level were significantly increased in TGF-ß1-509 TT and TNF-α-308 AA genotypes respectively. CONCLUSION: TGF-ß1-509 and TNF-α-308 genes polymorphisms are associated with risk of liver cirrhosis and HCC in patients with chronic HCV infection.


Subject(s)
Carcinoma, Hepatocellular/genetics , Hepatitis C, Chronic/complications , Liver Cirrhosis/genetics , Liver Neoplasms/genetics , Polymorphism, Single Nucleotide , Transforming Growth Factor beta1/genetics , Tumor Necrosis Factor-alpha/genetics , Aged , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/etiology , Female , Gene Frequency , Genotype , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/etiology , Liver Neoplasms/blood , Liver Neoplasms/etiology , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic/genetics , Risk Assessment , Risk Factors , Transforming Growth Factor beta1/blood , Tumor Necrosis Factor-alpha/blood
13.
Heart Vessels ; 27(3): 271-9, 2012 May.
Article in English | MEDLINE | ID: mdl-21584748

ABSTRACT

Heart failure with a normal ejection fraction (HFNEF) is common in obesity and coronary artery disease (CAD). Both ischemia and reperfusion induce leptin (LEP) and leptin receptor (LEPR) gene expression. We aimed to investigate the possible associations of serum leptin, leptin gene and leptin receptor gene polymorphism with HFNEF in patients with CAD. 100 Egyptian CAD patients with HFNEF and 100 healthy subjects (the control group) were genotyped for LEP and LEPR polymorphism. Leptin levels were measured. Serum leptin levels were significantly increased in patients compared to the control group. There was a significant increase in the leptin gene (AA genotype) and the leptin receptor gene (RR genotype) in HFNEF patients compared to the control group. Leptin levels, leptin gene (AA genotype) and LEPR (RR genotype) were more associated with NYHA III than with NYHA I and II. We thus concluded that HFNEF is associated with increased serum leptin levels, and the LEP AA genotype or LEPR RR genotype carries at least a threefold increased risk of developing HFNEF.


Subject(s)
Heart Failure/genetics , Leptin/genetics , Polymorphism, Genetic , Receptors, Leptin/genetics , Stroke Volume , Ventricular Function, Left , Adult , Aged , Analysis of Variance , Biomarkers/blood , Case-Control Studies , Chi-Square Distribution , Echocardiography, Doppler , Egypt , Female , Gene Frequency , Genetic Predisposition to Disease , Heart Failure/blood , Heart Failure/diagnostic imaging , Heart Failure/metabolism , Heart Failure/physiopathology , Humans , Leptin/blood , Lipids/blood , Male , Middle Aged , Odds Ratio , Phenotype , Regression Analysis , Risk Assessment , Risk Factors , Severity of Illness Index
14.
Cell Immunol ; 273(1): 67-72, 2012.
Article in English | MEDLINE | ID: mdl-22196377

ABSTRACT

Rheumatoid arthritis (RA) is the most common cause of adult inflammatory arthritis. Recent genome-wide association scans have disclosed several single-nucleotide polymorphisms associated with RA susceptibility. The aim of this study was to determine whether the polymorphisms of TRAF1/C5 (tumor necrosis factor (TNF)-receptor associated factor 1)/(complement component 5) and STAT4 (signal transducers and activators of transcription 4) confer susceptibility, activity and severity to RA in Egyptian populations. One hundred and seventy-two RA patients and 160 controls were enrolled in the study. Polymorphisms of TRAF1/C5 and STAT4 genes were determined using restriction fragment length polymorphism-polymerase chain reaction. The TRAF1/C5 A and STAT4 T alleles were significantly associated with RA in Egyptian population. TRAF1/C5 A allele and STAT4 TT genotype were significantly associated with RA severity. In conclusion the mutant alleles or genotypes of both examined polymorphisms are associated with the development of RA in Egyptian population.


Subject(s)
Arthritis, Rheumatoid/immunology , STAT4 Transcription Factor/immunology , TNF Receptor-Associated Factor 1/immunology , Adult , Aged , Arthritis, Rheumatoid/genetics , Chi-Square Distribution , DNA/chemistry , DNA/genetics , Egypt , Female , Genetic Predisposition to Disease , Genetic Variation , Genotype , Humans , Middle Aged , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Polymorphism, Single Nucleotide , Rheumatoid Factor/blood , STAT4 Transcription Factor/genetics , TNF Receptor-Associated Factor 1/genetics
15.
Brain Res Bull ; 86(1-2): 22-8, 2011 Aug 10.
Article in English | MEDLINE | ID: mdl-21763406

ABSTRACT

Doxorubicin (DOX) is considered one of the most important chemotherapeutic agents that is used for the treatment of solid tumors. Its long-term use can cause neurodegenerative disorders due to its prolonged activation of microglia. The present study proved that the use of epicatechin prior to DOX treatment significantly attenuated not only the increase in TNF-α, iNOS and NF-κB expressions but also the increase in TNF-α and total nitrite levels in brain tissue when compared with rats treated with DOX-only. Thus, our study revealed that epicatechin can be used for the treatment of neuroinflammation and also for preventing the development of neurodegenerative disease during antineoplastic therapy because of its protective role in attenuation of neurotoxic pro-inflammatory mediators including TNF-α, NF-κB, and iNOS.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Brain/drug effects , Catechin/pharmacology , Doxorubicin/toxicity , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Brain/cytology , Brain/metabolism , Brain/pathology , Catalase/metabolism , Catechin/therapeutic use , Encephalitis/chemically induced , Encephalitis/drug therapy , Encephalitis/pathology , Glutathione Peroxidase/metabolism , Humans , Male , Malondialdehyde/metabolism , Microglia/drug effects , Microglia/metabolism , NF-kappa B/genetics , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/genetics
16.
Mol Cell Biochem ; 354(1-2): 141-50, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21499891

ABSTRACT

Lipoprotein lipase (LPL) and Apolipoprotein C-III (APOC-III) play an important role in lipid metabolism. The aim of this study was to explore the possible associations of the gene polymorphisms (LPL HindIII, LPL Ser(447)-Ter and APOC3 SstI), diabetes mellitus, and plasma lipids with myocardial infarction. The polymorphisms were assessed by restriction assay in 200 Egyptian MI patients (100 diabetic and 100 non-diabetic) and 100 healthy controls. This study demonstrated that individuals with the H2H2 genotype or S2 allele have more than three times higher relative risk of suffering from MI than those carrying the H1H1 or S1S1. Type 2 DM mainly lowers HDL-C levels in MI patients who carry H2H2 or S2S2 genotype and increases TC, TG, and LDL levels in MI patients carrying H2H2 or S2S2 genotype compared with non-diabetic MI patients carrying the same genotypes. In S447X polymorphism, it was observed that DM led to loss of the protective lipid profile in MI patients carrying 447XX genotype. These findings suggest that H2H2 or S2S2 genotypes are associated with dyslipidemia and increased risk of myocardial infarction. The S447X polymorphism is associated with a favorable lipid profile. However, the association of diabetes mellitus with these polymorphisms leads to unfavorable lipid profile.


Subject(s)
Apolipoprotein C-III/genetics , Diabetes Mellitus, Type 2/complications , Genetic Association Studies , Lipoprotein Lipase/genetics , Myocardial Infarction/etiology , Polymorphism, Genetic , Adult , Body Mass Index , Case-Control Studies , Cholesterol/blood , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/genetics , Female , Gene Frequency , Genotype , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/blood , Myocardial Infarction/genetics , Sequence Analysis, DNA , Triglycerides/blood
17.
Clin Biochem ; 43(6): 553-8, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20026099

ABSTRACT

OBJECTIVE: We tested the association between PON1 polymorphism, PON1 activity, oxidative susceptibility of LDL and coronary artery disease in Egyptians. METHODS: PON1 polymorphism, serum PON1 activity, lipoprotein oxidation susceptibility and lipid profile were measured. RESULTS: Levels of HDL and paraoxonase activity were significantly decreased in CAD patients compared to control group, and in patients with three vessels compared to those of single or two vessels disease. High-activity allele (R) has a more atherogenic lipid profile than for the low activity allele (Q). PON1 RR genotype has nine fold risks to develop CAD in Egyptians while those with PON1 QR genotype have four fold risks. CONCLUSION: The PON1 activity is lower in subject with CAD and there is a significant relationship between activity of PON1 and the severity of coronary atherosclerosis. Also, we provide evidence of a significant association between R allele of the PON1 polymorphism and the development of coronary artery disease.


Subject(s)
Aryldialkylphosphatase/genetics , Coronary Artery Disease/enzymology , Coronary Artery Disease/genetics , Polymorphism, Single Nucleotide , Adult , Aged , Case-Control Studies , Coronary Artery Disease/blood , Egypt , Enzyme Activation/genetics , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Lipids/blood , Male , Middle Aged , Oxidation-Reduction , Polymorphism, Single Nucleotide/physiology , Promoter Regions, Genetic/genetics , Severity of Illness Index
18.
Biomed Pharmacother ; 2009 Mar 12.
Article in English | MEDLINE | ID: mdl-19303735

ABSTRACT

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

19.
J Pharm Pharmacol ; 60(9): 1237-42, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18718129

ABSTRACT

Fast food is high in energy density and low in essential micronutrient density, especially zinc (Zn), of which antioxidant processes are dependent. We have tested the hypothesis that frequent fast food consumption could induce oxidative damage associated with inflammation in weanling male rats in relevance to Zn deprivation, which could adversely affect testis function. Zn and iron (in plasma and testicular tissue), plasma antioxidant vitamins (A, E, and C), as well as testicular superoxide dismutase (SOD) and reduced glutathione (GSH), lipid peroxidation indexes (thiobarbituric acid reactive substances (TBARS) and lipoprotein oxidation susceptibility (LOS)), and inflammatory markers (plasma C-reactive protein (CRP) and testicular tumour necrosis factor-alpha (TNF-alpha)) were determined. Serum testosterone and histological examination of the testis were performed also. We found a severe decrease in antioxidant vitamins and Zn, with concomitant iron accumulation. Zinc deficiency correlated positively with SOD, GSH, antioxidant vitamins and testosterone, and negatively with TBARS, LOS, CRP and TNF-alpha, demonstrating a state of oxidative stress and inflammation. We concluded that micronutrient deficiency, especially Zn, enhanced oxidative stress and inflammation in testicular tissue leading to underdevelopment of testis and decreased testosterone levels.


Subject(s)
Inflammation/etiology , Oxidative Stress , Testis/metabolism , Zinc/deficiency , Animals , Antioxidants/metabolism , Ascorbic Acid/blood , Deficiency Diseases/etiology , Feeding Behavior , Iron/metabolism , Male , Micronutrients/deficiency , Nutritional Requirements , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Testosterone/blood , Vitamin A/blood , Vitamin E/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...